BioCentriq

BioCentriq project managers have worked on multiple cell therapy programs and our Business Development professionals can discuss the nuances of your unique journey from lab to clinic, or from early stage to later stage trial. BioCentriq is uniquely equipped to price our projects according to client requirements. However, BioCentriq utilizes a rapid or accelerated tech transfer process that consistently allows us to complete tech transfer in as short as six months. Once the BioCentriq team has reviewed that documentation, the teams will discuss whether anything is needed prior to proceeding to the next step, which would be a feasibility study conducted in our pilot plant. After the BioCentriq team has completed the feasibility study and both teams acknowledge success, we will move to pilot runs, which are conducted in our pilot plant at a scale that imitates or approaches the scale and process planned for clinical manufacturing in a GMP environment. BioCentriq is a full-service, collaborative cell therapy CDMO. Our goal is to advance cell therapy manufacturing to make life altering medicines and therapeutics more accessible to patients. BioCentriq's process development and MS&T teams specialize in helping small and mid-size biotech optimize and scale their therapies for clinical manufacturing.